Delivery Order SPE2DR25D3012-SPE2DR26F4F0X
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $12,208.88 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of December 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $11,571.48 delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed price contract. The order was competitively awarded without set-aside restrictions and is scheduled for completion by October 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $121,701.21 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 12, 2026, with completion scheduled for January 13, 2026. This firm fixed-price, competitively awarded contract—which includes no set-aside designation—will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a...
- The Defense Logistics Agency awarded a delivery order valued at $11,377.52 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on September 18, 2025, with completion scheduled for September 19, 2025. This firm fixed price, non-set-aside contract reflects a routine pharmaceutical procurement supporting federal medical supply requirements. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for the...
- The Defense Logistics Agency awarded a delivery order valued at $11,895.54 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price contract was competitively awarded without set-aside designation and is scheduled for completion by September 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality....
- The Defense Logistics Agency awarded a delivery order valued at $8,921.73 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 7, 2026, with completion expected by January 8, 2026. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as...
- The Defense Logistics Agency awarded a delivery order valued at $10,756.42 to AmerisourceBergen Drug Corp for the supply of Jardiance 10mg tablets (90-count) on November 18, 2025, with completion scheduled for December 16, 2025. This firm fixed-price, non-set-aside contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $11,643.53 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packaging) with a completion date of December 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,648.51 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract was executed on December 29, 2025, with an ultimate completion date of December 30, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $28,256.65 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract. This non-set-aside award was issued on January 15, 2026, with an ultimate completion date of January 16, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4F0XDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $111,070.82 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, non-set-aside contract was executed on January 15, 2026, with an ultimate completion date of January 16, 2026, and is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc., serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's medical supply chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 and extending through December 2026. The IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs worldwide. The Jardiance order represents a routine task order fulfilling federal demand for this diabetes medication through an established, competitively-awarded prime vendor contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $111.1k | 1/14/26 |